Polyclonal Antibody to Nerve Growth Factor IB (NGFIB)
| Code | Size | Price |
|---|
| PAD963Ra01-20ul | 20ul | £92.00 |
Quantity:
| PAD963Ra01-100ul | 100ul | £173.00 |
Quantity:
| PAD963Ra01-200ul | 200ul | £234.00 |
Quantity:
| PAD963Ra01-1ml | 1ml | £539.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Rat
Applications:
- Immunocytochemistry (ICC)
- Immunohistochemistry (IHC)
- Immunoprecipitation (IP)
- Western Blot (WB)
Further Information
Alternative Names:
GFRP1; HMR; N10; NAK-1; NGFIB; NP10; NUR77; TR3; DHR38; TIS1; Orphan nuclear receptor HMR; Testicular receptor 3; Nuclear receptor subfamily 4 group A member 1
Buffer Formulation:
0.01M PBS, pH7.4, containing 0.01% Proclin-300, 50% glycerol.
Item Name:
Nerve Growth Factor IB
Source:
Polyclonal antibody preparation
Usage:
Western blotting: 0.5-2ug/mL;1:170-650
Immunohistochemistry: 5-20ug/mL;1:17-65
Immunocytochemistry: 5-20ug/mL;1:17-65
Optimal working dilutions must be determined by end user.
Immunohistochemistry: 5-20ug/mL;1:17-65
Immunocytochemistry: 5-20ug/mL;1:17-65
Optimal working dilutions must be determined by end user.
Related Products
| Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recombinant Nerve Growth Factor IB (NGFIB) | RPD963Ra01 | Cloud-Clone Corp. | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||